The new RISE Medicare Product and Pharmacy Strategy Summit brings together Medicare Advantage product and Part D pharmacy leaders in one room. Expect practical takeaways on sustainability, compliance, Star Ratings performance, and the fast-changing pharmacy cost curve.
The RISE Medicare Product and Pharmacy Strategy Summit brings Medicare Advantage (MA) product design and Part D pharmacy strategy together to help plans connect benefit design decisions to pharmacy economics—while staying competitive amid tighter margins, shifting signals from the Centers for Medicare & Medicaid Services (CMS), and accelerating specialty-drug spend.
For many MA organizations, product “math” and pharmacy “math” can no longer be solved in separate rooms. The Inflation Reduction Act’s (IRA) Part D redesign, the continued rise of specialty drugs (including GLP-1s), and intensifying scrutiny of PBM arrangements are changing plan liability and member affordability at the same time. Layer on Star Ratings execution risk and evolving supplemental benefit oversight, and the need for tighter cross-functional alignment becomes urgent.
What: RISE Medicare Product and Pharmacy Strategy
When: June 11–12
Where: Fairmont Olympic Hotel, Seattl
The two-day event is designed for cross-functional MA teams that need shared assumptions, faster decisions, and cleaner execution from bid season through in-year operations. It will be helpful for MA product, pricing, and portfolio leaders; pharmacy and Part D strategy teams; actuarial, finance, and bid strategy teams; Stars/quality, member experience, and operations leaders; and compliance and governance stakeholders.
Agenda topics
The conference is organized to mirror how decisions get made inside plans and pairs product strategy with pharmacy strategy so teams can pressure-test tradeoffs in real time.
Sessions will address:
- Market and policy signals shaping 2027 planning: A “hot topics” look at pressures affecting MA plan strategy, plus a policy outlook on regulatory signals and what they mean for bids, benefit design, and pharmacy positioning.
- Making the MA math work in a tight funding environment: Practical approaches to balancing member value, Star Ratings performance, and sustainability as utilization and pharmacy costs rise.
- Part D after the IRA: The new economics of drug spending, formulary strategy in a redesigned benefit, and how plans are adjusting cost sharing and utilization management.
- Star Ratings and member disruption: Pharmacy Star Ratings strategy, adherence and operational challenges, and how to communicate formulary changes without increasing disruption risk.
- Portfolio choices under pressure: Specialized plan strategy (C-SNP/D-SNP/I-SNP) and the operational requirements to execute successfully.
- Vendor, PBM, and partnership strategy: Navigating oversight and transparency, and building partnerships tied to measurable outcomes.
The RISE Medicare Product and Pharmacy Strategy Summit takes place June 11–12 at the Fairmont Olympic Hotel in downtown Seattle. Click here to view the full agenda, speaker roster, and registration details.